![Sonia Vora](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sonia Vora
Corporate Secretary at Medarex, Inc.
Sonia Vora active positions
Companies | Position | Start | End |
---|---|---|---|
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Corporate Secretary | 2009-09-01 | - |
Career history of Sonia Vora
Former positions of Sonia Vora
Companies | Position | Start | End |
---|---|---|---|
ZymoGenetics, Inc.
![]() ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Secretary | 2010-10-12 | - |
Statistics
International
United States | 3 |
Operational
Corporate Secretary | 2 |
Sectoral
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
ZymoGenetics, Inc.
![]() ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Sonia Vora
- Experience